Lobeglitazone (CKD-501) is a thiazolidinedione class of antidiabetic agent acting as a potent agonist for both PPARα and PPARγ, working as an insulin sensitizer by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.

纯度：≥98%

CAS：607723-33-1